Evaluating the Efficacy of Opti-Speech for Speech Treatment

Vulintus

Status: Completed

Conditions: Prelingual Deafness; Dysarthria; Articulation Disorder

Treatments: Device: Opti-Speech

Study type: Interventional

Funder types: Other; Industry; NIH

Identifiers

NCT02705326

2R44DC013467 (U.S. NIH Grant/Contract)

VUL_2R44DC013467_OptiSpeech

Details and patient eligibility

About

The purpose of this study is to determine if feedback from a three-dimensional real-time visualization of the tongue, a program called Opti-Speech, can be used to improve speech.

Full description

Participants will be asked to complete the Goldman Fristoe Test of Articulation along with several other assessment tests. Then speech treatment, guided by Opti-Speech, will be provided to the participant for up to 10 treatment sessions. The participant will be asked to come back after the final treatment for a 2-month follow-up assessment.

Enrollment: 37 patients

Sex: All

Ages: 12 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• English speaking individuals with speech errors resulting from persistent speech sound disorder, individuals with dysarthria resulting from neurological disorders and individuals with pre-lingual or congenital deafness.

Exclusion criteria

• Cognitive impairments that affect their ability to understand and follow instructions by the treating speech language pathologists

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

37 participants in 1 patient group

Opti-Speech

Experimental group

Description:

Speech treatment will be guided by Opti-Speech's visual feedback of tongue movement during speech

Treatment:

Device: Opti-Speech